Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
Clinical trial NCT01772199 · COMPLETED
Trial details
- NCT number
- NCT01772199
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.